Clover Health Investments, Corp. reports results for the quarter ended June 30 - Earnings Summary
Clover Health Investments, Corp. reports results for the quarter ended June 30 - Earnings Summary
Clover Health Investments, Corp. CLOV.OQ reported quarterly adjusted earnings of 5 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -2 cents. The mean expectation of three analysts for the quarter was for earnings of 3 cents per share. Wall Street expected results to range from zero cents to 7 cents per share.
Revenue rose 55.6% to $743.17 million from a year ago; analysts expected $728.27 million.
The company reported quarterly net income of $28 million.
Clover Health Investments, Corp. shares had fallen by 18.5% this quarter and gained 81.7% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 25% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the managed healthcare peer group is "buy."
Wall Street's median 12-month price target for Clover Health Investments, Corp. is $4.13, about 3.5% below its last closing price of $4.27
This summary was machine generated from LSEG data August 5 at 09:55 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.03 | 0.05 | Beat |
Mar. 31 2026 | 0.03 | 0.07 | Beat |
Dec. 31 2025 | -0.10 | -0.10 | Met |
Sep. 30 2025 | -0.03 | -0.05 | Missed |